WuXi AppTec | Latest News & Updates - Dec 02, 2024 Release
Colin Smith, M.S. has left WuXi AppTec as a Senior Validation Engineer (Sterilization) in the United States to join Bracco Medical Technologies as a Sr. Design Assurance Engineer...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

WuXi AppTec
🌎 wuxiapptec.comWuXi AppTec is a global company headquartered in Shanghai, providing a comprehensive range of R&D and manufacturing services to the pharmaceutical and biotech industries. With operations across Asia, Europe, and North America, the company supports over 6,000 customers in advancing healthcare products through integrated services that include drug discovery, clinical research, and advanced therapies. WuXi AppTec aims to enable every drug to be made and every disease to be treated, receiving recognition for its commitment to sustainability and innovation.
WuXi AppTec - Latest News and Updates
- Colin Smith, M.S. has left WuXi AppTec as a Senior Validation Engineer (Sterilization) in the United States to join Bracco Medical Technologies as a Sr. Design Assurance Engineer.
- WuXi AppTec celebrated its 24th anniversary during the week of Thanksgiving, emphasizing belief in the journey of creating new and quality drugs.
- Elizabeth Bassett, Corporate Biosafety Manager at WuXi AppTec, invites applications for roles in cell and gene therapy development at the Navy Yard.
- WuXi AppTec is hosting a live seminar on November 27.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
